Health care referral service plans to hire 180 by 2019
Indianapolis-based HealthPro suggests health care providers to patients based on the providers’ prices, proximity and availability.
Health Care Businesses
Articles
Former Lilly partner set to pay $2.3B to settle Actos cases
Takeda Pharmaceutical Co. executives have agreed to pay more than $2.3 billion to resolve lawsuits accusing the company of hiding its Actos diabetes medicine’s cancer risks, three people familiar with the accord said.
Efficiency, slide in patients drive IU Health’s $1B consolidation
The hospital system announced Friday that it would close its University hospital in downtown Indianapolis after expanding the nearby Methodist and Riley campuses.
IU Health to close University hospital, expand Riley, Methodist
Indiana University Health announced Friday that the $1 billion project consolidating its downtown hospitals will take five to seven years to complete, during which time University Hospital will remain open to patients just as it is now.
Princeton loses appeal in case sparked by Lilly drug loyalties
Four residents of the town of Princeton sued to revoke the university’s tax exemption, in part because it shares royalties with faculty, mostly from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.
Lawsuit: IU Health, HealthNet defrauded feds, endangered patients
The lawsuit charges that IU Health and HealthNet Inc. put low-income pregnant women and their newborn babies at risk in a fraud scheme that bilked taxpayers out of millions of dollars.
Loss of special perks chops Anthem CEO’s compensation to $13.5M
The Indianapolis-based health insurer raised pay for its executives, including CEO Joe Swedish, at a much slower pace than the 38-percent return it generated for shareholders last year.
Plug pulled on WFYI radio’s ‘Sound Medicine’ show
After 15 years on the air, "Sound Medicine" will broadcast its last new episode on April 26. The Indiana University School of Medicine, the show's primary funder, wants to change the direction of its marketing.
Alzheimer’s debate revived by new Mayo Clinic study
New research from the Mayo Clinic is bringing back a long-running debate over whether drug companies like Eli Lilly and Biogen are focusing on the right target in developing therapies to treat the disease.
Pay dips, but pension values soar for Lilly’s top execs
The top five executives at Eli Lilly and Co. took home 5 percent to 10 percent less in cash, stock and perks last year than the year before, according to a Monday securities filing.
Indiana House backs 3-year ban on building nursing homes
Indiana would have a three-year moratorium on construction of most new nursing homes under a proposal the state House narrowly approved Tuesday.
Lilly joins $100M global Alzheimer’s venture fund
Major drugmakers—including Indianapolis-based Eli Lilly and Co.—the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or cure.
Can Hc1 become the Salesforce.com of health care?
Zionsville-based Hc1 is using its latest round of funding to expand from its roots—making software to help medical labs, pharmacies, physicians and hospital systems track the business relationships they have with one another—into a company that also helps those organizations interact directly with patients.
Injured diver starts clinic that fills void in therapy
Chris Leeuw opened the doors of the NeuroHope rehab clinic on Feb. 18 to offer patients more time to recover and to help them remain healthy in spite of their immobilizing spinal cord and brain injuries.
Warnings ordered on testosterone drugs like Lilly’s Axiron
Makers of testosterone drugs must change the products’ labels to clarify that they are approved for only certain disorders, not to help men deal with aging, U.S. regulators said.
Lilly to introduce Lantus copy in Europe after patent expires
Paris-based drugmaker Sanofi had revenue of $8.4 billion from Lantus last year. It lost U.S. patent protection this month and will lose exclusive rights in Europe in May.
Lilly to delay U.S., EU approval of basal insulin
Although the experimental diabetes drug is in final-stage testing and showing promising results, Lilly wants to better understand its effect on liver fat.
Feds finally end probe into Lilly bribery allegations
The U.S. Department of Justice told Lilly last month its investigation was over—more than a year after the drugmaker paid $29 million to the SEC to settle related bribery allegations.
Six central Indiana dental employees reach plea deals
Prosecutors have struck plea agreements with six former employees of an Anderson dental clinic in connection with a Medicaid fraud investigation.
Lawmakers aim to restrict access to meth ingredients
The leaders of Indiana communities hit hard by methamphetamine are arguing for a state law requiring prescriptions to buy cold and allergy pills.